Ongoing and future trials of biologic therapies in lung cancer

Paul A. Bunn, Frances A. Shepherd, Alan Sandler, Thierry Le Chevalier, Chandra Belani, Paris A. Kosmidis, Giorgio V. Scagliotti, Giuseppe Giaccone

Research output: Contribution to journalArticlepeer-review

22 Scopus citations


Lung cancer is the leading world-wide cause of cancer death. The care rate remains less than 15% despite improvements in surgery, radiotherapy and chemotherapy. The majority of deaths can be attributed to systemic metastases. Chemotherapy prolongs survival but produces few complete responses and survival at 5-years is rare. Molecular advances have provided many new targets for lung cancer therapy. Many new agents have been developed to attack these targets. This article describes current and proposed trials for these new targeted therapies in both small cell and non-small cell lung cancers.

Original languageEnglish (US)
Pages (from-to)175-186
Number of pages12
JournalLung Cancer
Issue numberSUPPL. 1
StatePublished - Aug 1 2003

All Science Journal Classification (ASJC) codes

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research


Dive into the research topics of 'Ongoing and future trials of biologic therapies in lung cancer'. Together they form a unique fingerprint.

Cite this